Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 25;117(8):4117-4124.
doi: 10.1073/pnas.1911998117. Epub 2020 Feb 11.

Basis for metabolite-dependent Cullin-RING ligase deneddylation by the COP9 signalosome

Affiliations

Basis for metabolite-dependent Cullin-RING ligase deneddylation by the COP9 signalosome

Hong Lin et al. Proc Natl Acad Sci U S A. .

Abstract

The Cullin-RING ligases (CRLs) are the largest family of ubiquitin E3s activated by neddylation and regulated by the deneddylase COP9 signalosome (CSN). The inositol polyphosphate metabolites promote the formation of CRL-CSN complexes, but with unclear mechanism of action. Here, we provide structural and genetic evidence supporting inositol hexakisphosphate (IP6) as a general CSN cofactor recruiting CRLs. We determined the crystal structure of IP6 in complex with CSN subunit 2 (CSN2), based on which we identified the IP6-corresponding electron density in the cryoelectron microscopy map of a CRL4A-CSN complex. IP6 binds to a cognate pocket formed by conserved lysine residues from CSN2 and Rbx1/Roc1, thereby strengthening CRL-CSN interactions to dislodge the E2 CDC34/UBE2R from CRL and to promote CRL deneddylation. IP6 binding-deficient Csn2K70E/K70E knockin mice are embryonic lethal. The same mutation disabled Schizosaccharomyces pombe Csn2 from rescuing UV-hypersensitivity of csn2-null yeast. These data suggest that CRL transition from the E2-bound active state to the CSN-bound sequestered state is critically assisted by an interfacial IP6 small molecule, whose metabolism may be coupled to CRL-CSN complex dynamics.

Keywords: COP9 signalosome; Cullin-RING ligases; deneddylation; inositol hexakisphosphate; intermolecular glue.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interest.

Figures

Fig. 1.
Fig. 1.
IP6 is a CSN cofactor. (AC) Quantitative ITC measurement of the interaction between IP6 and CSN2 (A), Cul4A/Rbx1 (B), or CSN2–Cul4A/Rbx1 complex (C). n.d.: Not determined because of weak binding. (D) Mass spectra of myc-CSN2 immunoprecipitate. (Lower) Zoom-in spectra highlighting the mass corresponding to [IP6]−2. (Inset) CSN2 Western blot of wild-type and myc-CSN2 stable cells. (E) Deneddylation of purified Nedd8–Cul4A/Rbx1 by recombinant CSN prepared from E. coli (IP6-free), in the presence/absence of IP6. (F and G) In-lysate Cul4A deneddylation at the indicated time points in the absence/presence of exogenous IP6 (F), or in control and CRISPR-mediated IP5K KO cells (G). Repeated three times. Cells were lysed in the absence of protease inhibitor to keep CSN activity. Note that some deneddylation occurs during cell lysis and before experimental time “0”. (Lower) Scatter plot quantifying the half-life of Nedd8-Cul4A. l.e., long exposure s.e., short exposure.
Fig. 2.
Fig. 2.
Structural basis of the IP6–CSN2 complex. (A) Surface representation of the IP6–CSN2–T4 crystal structure. IP6 is shown as stick with cyan backbone and buried in an electropositive (blue) pocket. (B) The IP6–CSN2 crystal structure highlighting a 2FoFc omit electron density map of IP6 contoured at 1.2σ. (C) Rotated view of the IP6–CSN2 complex highlighting the cluster of basic residues coordinating IP6. (D) Sequence alignment of IP6-coordinating residues from Rbx1/2 across species. At: Arabidopsis thaliana; Ce: Caenorhabditis elegans; Dm: Drosophila melanogaster; Dr: Danio reiro; Gg: Gallus gallus; Hs: Homo sapiens; Mm: Mus musculus; Sc: Saccharomyces cerevisiae; Sp: Schizosaccharomyces pombe. (E) In vitro binding between HEK293-purified, salt-stripped GST–Cul4A/Rbx1 and bacterially purified recombinant CSN2 variants that are defective in binding IP6. The mutants fail to show augmented Cul4A/Rbx1 binding in the presence of IP6. (F) GST pulldown of CSN2 wild-type and IP6 binding-defective mutants from cell lysates.
Fig. 3.
Fig. 3.
Structural and functional insights into the IP6–CSN–CRL interface. (A) Fitting of the Nedd8–CRL4A–CSN electron density map (EMD-3314, 6.4 Å) with crystal structures of the subcomponents. (B) Close-up view of the IP6–CRL–CSN ternary complex. IP6 is positioned based on the IP6–CSN2 crystal structure. (C) Electrostatic complementarity between IP6 and its basic binding pocket. (D) Sequence alignment of IP6-coordinating residues from Rbx1/2 across species. At: Arabidopsis thaliana; Ce: Caenorhabditis elegans; Dm: Drosophila melanogaster; Dr: Danio reiro; Gg: Gallus gallus; Hs: Homo sapiens; Mm: Mus musculus; Sc: Saccharomyces cerevisiae; Sp: Schizosaccharomyces pombe. (E) GST pulldown of Cul4A coexpressed with Rbx1 wild-type or mutants. (F) In vitro binding between recombinant CSN2 and HEK293-purified GST–Cul4A coexpressed with myc-Rbx1 wild-type or the various mutants, with/without IP6. (G) Molecular structures of biotin (2)-IP6 (i) and biotin (5)-IP6 (ii). For synthesis details, see extended data. (H) Biotin (5)-IP6 but not biotin (2)-IP6 substitutes IP6 in stimulating in vitro interaction between purified recombinant CSN2 and Cul4A/Rbx1. (I) Pulldown of CSN2 and Cul4A from whole cell lysate by biotin (5)-IP6 but not biotin (2)-IP6.
Fig. 4.
Fig. 4.
IP6 promotes CSN-CRL4 complex reassembly by augmenting competition against CDC34, thereby protecting substrate receptor. (A) Recombinant purified CDC34 dose-dependently competes with CSN2 for Cul4A/Rbx1 binding in vitro. (B) IP6 facilitates CSN2 to compete with CDC34 for binding to Cul4A/Rbx1. (C) Relative binding of Cul4A/Rbx1 to immobilized CSN2 in the presence/absence of CDC34 and/or IP6 (***P < 0.001, student’s t test; n.s., not significant). An anti-Cul4A antibody was used to detect the ELISA (enzyme-linked immunosorbent assay) signal. (D) IP5K knockdown diminishes the interaction between Cul4A and CSN2. (E) IP5K knockdown enhances Cul4A-CDC34 interaction while diminishes the levels of DDB2. (F) Effects of overexpressing Rbx1 wild-type or the IP6-binding defective K25E/K26E mutant on Cul4A neddylation and DDB2 levels. (G) Scheme depicting the role of IP6 in facilitating the sequestration of CRL by CSN, thereby completing the CRL activity cycle. Other proposed CRL activation steps would include: 1) Substrate-induced CSN-dissociation (1′: CAND1-mediated adaptor exchange) (11, 13); 2) Neddylation; 3) ARIH-mediated mono-Ub priming (50); 4) CDC34-dependent Ub-chain elongation and substrate degradation (23). N8: Nedd8; R: Rbx1/Roc1; SR: substrate receptor; Sub: substrate; Ub: ubiquitin; 2: CSN2.
Fig. 5.
Fig. 5.
IP6 is a general CRL regulator conserved from yeast to mammals. (AC) GST pulldown of cellular Cul1 (A), Cul2 (B), Cul3 (C) coexpressed with Rbx1 wild-type or mutants deficient in IP6 coordination. Rbx1 mutations disrupting IP6 coordination also abolish CSN interaction with Cul1–3. (D) GST pulldown of CSN2 wild-type and IP6 binding-defective mutants from cell lysates, CSN2 mutations disrupting IP6 coordination also fail to pull down Cul1–5. (E) Deneddylation of purified Nedd8–Cul3/Rbx1 by recombinant CSN, with/without IP6 at the indicated concentrations. (F) Levels of Cullin neddylation in wild-type and IP5K KO cells. *P < 0.05, **P < 0.01. (G) Coimmunoprecipitation between myc-Cul1 and TAP-Csn2, each tagged at endogenous locus in wild-type and Δipk1 S. pombe strains. Cul–Csn2 interaction is abolished in the Δipk1 mutant. (H) UV sensitivity of a Δcsn2 strain rescued with wild-type Csn2, but not the K70E mutant. **P < 0.01.

Comment in

Similar articles

Cited by

References

    1. Petroski M. D., Deshaies R. J., Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 6, 9–20 (2005). - PubMed
    1. Lydeard J. R., Schulman B. A., Harper J. W., Building and remodelling Cullin-RING E3 ubiquitin ligases. EMBO Rep. 14, 1050–1061 (2013). - PMC - PubMed
    1. Skaar J. R., Pagan J. K., Pagano M., SCF ubiquitin ligase-targeted therapies. Nat. Rev. Drug Discov. 13, 889–903 (2014). - PMC - PubMed
    1. Bondeson D. P., Crews C. M., Targeted protein degradation by small molecules. Annu. Rev. Pharmacol. Toxicol. 57, 107–123 (2017). - PMC - PubMed
    1. Liu X, et al. , Cand1-mediated adaptive exchange mechanism enables variation in F-box protein expression. Mol. Cell 69, 773–786.e6 (2018). - PMC - PubMed

Publication types

Associated data